EcoDrugPlus

Probable Histone Deacetylase 1-B

Ensembl ID : ENSLCRG00005016179
Gene Symbol: LOC104919311
3 Cross references
255 Possible Orthologues:

Progesterone Receptor

Ensembl ID : ENSLCRG00005004469
Gene Symbol: PGR
3 Cross references
193 Possible Orthologues:

Progesterone Receptor-Like

Ensembl ID : ENSLCRG00005009909
Gene Symbol: LOC104925167
2 Cross references
206 Possible Orthologues:

Prostaglandin D2 Receptor 2

Ensembl ID : ENSLCRG00005003374
Gene Symbol: PTGDR2
3 Cross references
135 Possible Orthologues:

Prostaglandin D2 Receptor 2

Ensembl ID : ENSLCRG00005009134
Gene Symbol: LOC109141869
2 Cross references
145 Possible Orthologues:

Prostaglandin E Receptor 1a (Subtype Ep1)

Ensembl ID : ENSLCRG00005016658
Gene Symbol: PTGER1A
3 Cross references
167 Possible Orthologues:

Prostaglandin E Receptor 2a (Subtype Ep2)

Ensembl ID : ENSLCRG00005003864
Gene Symbol: PTGER2A
3 Cross references
202 Possible Orthologues:

Prostaglandin E Receptor 3

Ensembl ID : ENSLCRG00005022020
Gene Symbol: PTGER3
1 Cross references
170 Possible Orthologues:

Prostaglandin E Receptor 3

Ensembl ID : ENSLCRG00005022021
Gene Symbol: PTGER3
3 Cross references
175 Possible Orthologues:

Prostaglandin E Receptor 4 (Subtype Ep4) A

Ensembl ID : ENSLCRG00005004513
Gene Symbol: PTGER4A
3 Cross references
202 Possible Orthologues:

Prostaglandin E Receptor 4 (Subtype Ep4) B

Ensembl ID : ENSLCRG00005004617
Gene Symbol: PTGER4B
3 Cross references
201 Possible Orthologues:

Prostaglandin E2 Receptor Ep1 Subtype

Ensembl ID : ENSLCRG00005013618
Gene Symbol: LOC104930238
3 Cross references
164 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).